Research shows the presence of cloudy effluent in peritoneal dialysis-associated peritonitis is highly predictive of ...

FDC informed that the drug maker has received final approval from United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Cefixime 400 mg tablets.

Cefixime is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines ...

Innoviva (INVA) announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica for the commercialization of Zevtera, an advanced-generation cephalosporin ...

Innoviva, Inc. (INVA) announced Monday that its unit Innoviva Specialty Therapeutics, Inc. or IST has entered into an exclusive ...

Innoviva Specialty Therapeutics, Inc., ("IST") a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced it has entered ...

Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland, December 16, 2024Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a ...

The global market for complicated urinary tract infections treatment is poised for impressive growth over the next decade, ...

FDA approves zenocutuzumab for advanced non-small-cell lung cancer and pancreatic cancer with NRG1 fusion, offering new hope ...

The authors sought to study whether extended or continuous infusion of cephalosporins is associated with better clinical outcomes than short-term infusion. PubMed and Scopus databases were ...